Astellas Names VP, Clinical Pharmacology and Exploratory Development

From DCAT Value Chain Insights (VCI)

By People On The Move posted 04-12-2016 15:14


Astellas has named Joseph Fleishaker, PhD, as vice president, clinical pharmacology and exploratory development. Fleishaker will be located at Astellas' global headquarters for the medical and development organization in Northbrook, Illinois and will report to Dr. Bernie Zeiher, president, Development.

Fleishaker will oversee the clinical pharmacology and exploratory development function,which includes all clinical pharmacology, pharmacokinetics, modeling and simulation support for early as well as late-stage development programs. As a member of the Development Leadership Team, Fleishaker will play an instrumental role in leading this functional area to fully characterize clinical candidates.

Since joining Astellas in 2012, Fleishaker has made significant contributions to the growing and evolving neuroscience portfolio. Most recently at Astellas, he served as vice president and global therapeutic head of neuroscience and previously held the role of executive director and project lead of development, leading the CNS/Pain therapeutic area.

Source: Astellas


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription